Patent · US Expired

Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV

US6319893A · kind A · utility

61Cited by
8References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 1999
Grant dateNov 20, 2001
Priority date
Expiry dateAug 2, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of raising the blood sugar level in a mammal having hypoglycemia is described. The method reduces degradation of glucagon by administering to the mammal a therapeutically effective amount of an inhibitor of dipeptidyl peptidase IV and physiologically acceptable adjuvants and/or excipients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.